ips cells
Bringing Sight To The Blind
Professor Masayo Takahashi, who performed the world's first induced pluripotent stem cell-derived transplant into humans, has a vision for stem cells in the clinic.
Cell Conversion? There’s An App For That
Mogrify is an algorithm that helps researchers predict the set of transcription factors required to convert one cell type into another.
CiRA & Takeda Announce Joint iPS Cell Research
Takeda, Japan's largest pharmaceutical company, will provide US$166 million of funding for iPS research over the next ten years.
Stone Man Syndrome Linked To Inflammation
Induced pluripotent stem cells have helped scientists uncover a new mechanism for the development of Stone Man Syndrome, narrowing down the search for much needed therapies.
The State Of Regenerative Medicine 20 Years After ‘Earmouse’
It's been 20 years since the appearance of earmouse, how far has regenerative medicine come since then?
Human iPS-Derived Kidneys Successfully Hook Up To Blood Vessels
In a world first, researchers have successfully connected mouse kidney capillaries with kidney tissue derived from human induced pluripotent stem cells.
Animal-Free Screening For Nephrotoxicity
By combining iPS cells with machine learning, researchers have developed an efficient and accurate screening platform to detect compounds that are toxic to the kidneys.
First iPSC Transplant Patient Doing Well
The first patient to receive an iPS cell transplant has shown no tumor formation since her surgery in 2014.
Oncogene Identified As Inhibitor Of Cell Reprogramming
Inhibiting the well-known oncogene c-Jun could make it easier to turn somatic cells into induced pluripotent stem cells, study says.
